Immunohistochemical assessment of tumour behaviour and patient prognosis in human breast cancer.
Barnes
D M
DM
ICRF Clinical Oncology Unit, Guy's Hospital, London, U.K.
D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000235:genetics; D002278:Carcinoma in Situ / Q000175:diagnosis / Q000235:genetics; D016147:Genes, Tumor Suppressor; D016158:Genes, p53; D006801:Humans; D007159:Immunologic Tests; D011379:Prognosis; D011518:Proto-Oncogene Proteins / Q000235:genetics / Q000276:immunology; D011519:Proto-Oncogenes; D018719:Erb-b2 Receptor Tyrosine Kinases; D016159:Tumor Suppressor Protein p53 / Q000235:genetics / Q000276:immunology
D014408:Biomarkers, Tumor; D011518:Proto-Oncogene Proteins; D018719:Erb-b2 Receptor Tyrosine Kinases; D016159:Tumor Suppressor Protein p53